<p>PetMed Express, Inc.（納斯達克代碼：PETS - 獲取免費報告）在 12 月份的空頭頭寸出現了顯著下降。截至 12 月 31 日，空頭頭寸總計為 1,056,449 股，較 12 月 15 日的 2,698,921 股下降了 60.9%。目前，該股票的 5.0% 股份被做空。根據平均每日交易量 1,489,468 股，空頭頭寸比率目前為 0.7 天。</p>
<p>獲取 <strong>PetMed Express</strong> 警報：</p>
<h2>機構資金流入和流出</h2>
<ul>
<li>Petco Health &amp; Wellness 在每股收益超預期後是否擺脱困境？</li>
</ul>
<p>幾家機構投資者和對沖基金最近對該股票的持倉進行了調整。R Squared Ltd 在第二季度購買了價值約 34,000 美元的 PetMed Express 新股份。Occudo Quantitative Strategies LP 在第二季度獲得了價值約 51,000 美元的 PetMed Express 新持倉。Oxford Asset Management LLP 在第二季度獲得了價值約 55,000 美元的 PetMed Express 新持倉。CIBC Private Wealth Group LLC 在第三季度購買了價值約 75,000 美元的 PetMed Express 新持倉。最後，Bridgeway Capital Management LLC 在第二季度將其在 PetMed Express 的股份增加了 96.2%。Bridgeway Capital Management LLC 目前擁有 40,800 股該公司股票，價值 135,000 美元，此前在上個季度又購買了 20,000 股。目前，73.33% 的股票由機構投資者持有。</p>
<h2>PetMed Express 股票上漲 1.7%</h2>
<p>週三，PETS 股票上漲 0.06 美元，達到 3.49 美元。該股票交易了 174,936 股，較其平均交易量 337,258 股有所減少。該公司的市值為 7458 萬美元，市盈率為-1.32，貝塔值為 0.65。該公司有 50 日移動平均線為 2.66 美元，200 日移動平均線為 2.85 美元。PetMed Express 的 1 年最低價為 1.57 美元，1 年最高價為 5.58 美元。</p>
<ul>
<li>這是唯一一隻不在困境中的寵物股票</li>
</ul>
<p>PetMed Express（納斯達克代碼：PETS - 獲取免費報告）最後一次發佈財報是在 12 月 19 日，週五。該公司報告每股收益（EPS）為（0.41）美元，低於分析師一致預期的 0.04 美元，差距為（0.45）美元。PetMed Express 的股本回報率為-40.26%，淨利潤率為-28.22%。該業務在本季度的收入為 4436 萬美元。根據分析師的預測，PetMed Express 在當前財年將發佈 0.19 美元的每股收益。</p>
<h2>華爾街分析師預測增長</h2>
<p>多位分析師對 PETS 股票發佈了報告。Wall Street Zen 在 10 月 18 日的研究報告中將 PetMed Express 的評級從 “持有” 下調至 “賣出”。Zacks Research 在 9 月 29 日的研究報告中將 PetMed Express 的評級從 “強烈賣出” 上調至 “持有”。最後，Weiss Ratings 在 12 月 29 日的研究報告中重申了對 PetMed Express 的 “賣出（e+）” 評級。一位分析師對該股票給予了 “持有” 評級，兩位分析師給予了 “賣出” 評級。根據 MarketBeat 的數據，該公司目前的平均評級為 “賣出”，平均目標價為 3.20 美元。</p>
<ul>
<li>這 5 只寵物護理股票中的一隻可能成為下一個空頭擠壓</li>
</ul>
<p><strong>閲讀我們關於 PETS 的最新報告</strong></p>
<h2>PetMed Express 公司簡介</h2>
<p>（獲取免費報告）</p>
<p>PetMed Express, Inc.以 1-800-PetMeds 品牌名義運營，作為一家在線和目錄基礎的寵物藥房和零售供應商。該公司直接向消費者分發處方和非處方藥物、營養補充劑、跳蚤和蜱蟲控制產品以及一系列寵物健康用品。通過其位於佛羅里達州德爾雷海灘的持牌獸醫藥房，PetMed Express 為狗、貓和其他伴侶動物處理訂單，提供品牌和仿製產品以及自有品牌配方。</p>
<p>PetMed Express 於 1996 年由 Marc Puleo 創立，基於為尋求可靠獸醫藥物的寵物主人提供便利和節省成本的理念建立了其業務。</p>
<h2>推薦故事</h2>
<ul>
<li>五隻我們更看好的股票比 PetMed Express 更好</li>
<li>這個 AI 機會旨在隨着需求的變化而發展</li>
<li>將這些代碼輸入您的普通經紀賬户</li>
<li>家族信託如何幫助保護您的財富</li>
<li>為什麼特朗普和馬斯克突然關心福特諾克斯</li>
<li>一項價值數萬億的美國 “出生權” 索賠 - 靜悄悄地激活</li>
</ul>
<p><em>此即時新聞警報由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 PetMed Express 嗎？</h2>
<p>在考慮 PetMed Express 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買……而 PetMed Express 並不在名單上。</p>
<p>雖然 PetMed Express 目前在分析師中被評為 “賣出”，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

PETS

<p>PetMed Express, Inc.（納斯達克代碼：PETS）在短期空頭頭寸方面經歷了顯著下降，12 月份下降了 60.9%，降至 1,056,449 股。目前，其 5.0% 的股份被做空，基於平均每日成交量 1,489,468 股，覆蓋天數比率為 0.7 天。股價上漲了 1.7%，達到 3.49 美元，市值為 7458 萬美元。分析師的評級意見不一，平均目標價為 3.20 美元，顯示出總體看跌的前景</p>

<p>PetMed Express, Inc. (NASDAQ:PETS - Get Free Report) was the target of a significant drop in short interest in December. As of December 31st, there was short interest totaling 1,056,449 shares, a drop of 60.9% from the December 15th total of 2,698,921 shares. Currently, 5.0% of the shares of the stock are sold short. Based on an average daily volume of 1,489,468 shares, the short-interest ratio is presently 0.7 days. Based on an average daily volume of 1,489,468 shares, the short-interest ratio is presently 0.7 days. Currently, 5.0% of the shares of the stock are sold short.</p>
<div class="lb-trans"><p>PetMed Express, Inc.（納斯達克代碼：PETS - 獲取免費報告）在 12 月份的空頭頭寸出現了顯著下降。截至 12 月 31 日，空頭頭寸總計為 1,056,449 股，較 12 月 15 日的 2,698,921 股下降了 60.9%。目前，該股票的 5.0% 股份被做空。根據平均每日交易量 1,489,468 股，空頭頭寸比率目前為 0.7 天。</p>
</div><p>Get <strong>PetMed Express</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>PetMed Express</strong> 警報：</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>機構資金流入和流出</h2>
</div><ul>
<li>Is Petco Health &amp; Wellness Out of the Doghouse on an EPS beat?</li>
</ul>
<div class="lb-trans"><ul>
<li>Petco Health &amp; Wellness 在每股收益超預期後是否擺脱困境？</li>
</ul>
</div><p>Several institutional investors and hedge funds have recently made changes to their positions in the stock. R Squared Ltd purchased a new stake in PetMed Express during the second quarter valued at about $34,000. Occudo Quantitative Strategies LP acquired a new position in shares of PetMed Express during the second quarter worth approximately $51,000. Oxford Asset Management LLP acquired a new position in PetMed Express in the 2nd quarter valued at approximately $55,000. CIBC Private Wealth Group LLC bought a new position in shares of PetMed Express during the 3rd quarter worth about $75,000. Finally, Bridgeway Capital Management LLC boosted its stake in PetMed Express by 96.2% in the 2nd quarter. Bridgeway Capital Management LLC now owns 40,800 shares of the company's stock valued at $135,000 after buying an additional 20,000 shares in the last quarter. 73.33% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>幾家機構投資者和對沖基金最近對該股票的持倉進行了調整。R Squared Ltd 在第二季度購買了價值約 34,000 美元的 PetMed Express 新股份。Occudo Quantitative Strategies LP 在第二季度獲得了價值約 51,000 美元的 PetMed Express 新持倉。Oxford Asset Management LLP 在第二季度獲得了價值約 55,000 美元的 PetMed Express 新持倉。CIBC Private Wealth Group LLC 在第三季度購買了價值約 75,000 美元的 PetMed Express 新持倉。最後，Bridgeway Capital Management LLC 在第二季度將其在 PetMed Express 的股份增加了 96.2%。Bridgeway Capital Management LLC 目前擁有 40,800 股該公司股票，價值 135,000 美元，此前在上個季度又購買了 20,000 股。目前，73.33% 的股票由機構投資者持有。</p>
</div><h2>PetMed Express Stock Up 1.7%</h2>
<div class="lb-trans"><h2>PetMed Express 股票上漲 1.7%</h2>
</div><p>Shares of PETS stock traded up $0.06 on Wednesday, reaching $3.49. 174,936 shares of the stock were exchanged, compared to its average volume of 337,258. The stock has a market cap of $74.58 million, a P/E ratio of -1.32 and a beta of 0.65. The firm has a 50 day moving average of $2.66 and a two-hundred day moving average of $2.85. PetMed Express has a 1-year low of $1.57 and a 1-year high of $5.58.</p>
<div class="lb-trans"><p>週三，PETS 股票上漲 0.06 美元，達到 3.49 美元。該股票交易了 174,936 股，較其平均交易量 337,258 股有所減少。該公司的市值為 7458 萬美元，市盈率為-1.32，貝塔值為 0.65。該公司有 50 日移動平均線為 2.66 美元，200 日移動平均線為 2.85 美元。PetMed Express 的 1 年最低價為 1.57 美元，1 年最高價為 5.58 美元。</p>
</div><ul>
<li>Here’s The One Pet Stock That’s Not in the Doghouse</li>
</ul>
<div class="lb-trans"><ul>
<li>這是唯一一隻不在困境中的寵物股票</li>
</ul>
</div><p>PetMed Express (NASDAQ:PETS - Get Free Report) last posted its earnings results on Friday, December 19th. The company reported ($0.41) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.04 by ($0.45). PetMed Express had a negative return on equity of 40.26% and a negative net margin of 28.22%.The business had revenue of $44.36 million for the quarter. On average, equities research analysts predict that PetMed Express will post 0.19 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>PetMed Express（納斯達克代碼：PETS - 獲取免費報告）最後一次發佈財報是在 12 月 19 日，週五。該公司報告每股收益（EPS）為（0.41）美元，低於分析師一致預期的 0.04 美元，差距為（0.45）美元。PetMed Express 的股本回報率為-40.26%，淨利潤率為-28.22%。該業務在本季度的收入為 4436 萬美元。根據分析師的預測，PetMed Express 在當前財年將發佈 0.19 美元的每股收益。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>華爾街分析師預測增長</h2>
</div><p>A number of analysts have issued reports on PETS shares. Wall Street Zen downgraded PetMed Express from a &#34;hold&#34; rating to a &#34;sell&#34; rating in a research note on Saturday, October 18th. Zacks Research raised shares of PetMed Express from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a research report on Monday, September 29th. Finally, Weiss Ratings restated a &#34;sell (e+)&#34; rating on shares of PetMed Express in a research note on Monday, December 29th. One analyst has rated the stock with a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of &#34;Sell&#34; and an average target price of $3.20.</p>
<div class="lb-trans"><p>多位分析師對 PETS 股票發佈了報告。Wall Street Zen 在 10 月 18 日的研究報告中將 PetMed Express 的評級從 “持有” 下調至 “賣出”。Zacks Research 在 9 月 29 日的研究報告中將 PetMed Express 的評級從 “強烈賣出” 上調至 “持有”。最後，Weiss Ratings 在 12 月 29 日的研究報告中重申了對 PetMed Express 的 “賣出（e+）” 評級。一位分析師對該股票給予了 “持有” 評級，兩位分析師給予了 “賣出” 評級。根據 MarketBeat 的數據，該公司目前的平均評級為 “賣出”，平均目標價為 3.20 美元。</p>
</div><ul>
<li>One of these 5 Pet Care Stocks Can Be the Next Short Squeeze</li>
</ul>
<div class="lb-trans"><ul>
<li>這 5 只寵物護理股票中的一隻可能成為下一個空頭擠壓</li>
</ul>
</div><p><strong>Read Our Latest Report on PETS</strong></p>
<div class="lb-trans"><p><strong>閲讀我們關於 PETS 的最新報告</strong></p>
</div><h2>PetMed Express Company Profile</h2>
<div class="lb-trans"><h2>PetMed Express 公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>PetMed Express, Inc operates as an online and catalog-based pet pharmacy and retail supplier under the 1-800-PetMeds brand name. The company distributes prescription and non‐prescription medications, nutritional supplements, flea and tick control products, and a range of pet health supplies directly to consumers. Through its licensed veterinary pharmacy in Delray Beach, Florida, PetMed Express fills orders for dogs, cats and other companion animals, offering both branded and generic products alongside its own private‐label formulations.</p>
<div class="lb-trans"><p>PetMed Express, Inc.以 1-800-PetMeds 品牌名義運營，作為一家在線和目錄基礎的寵物藥房和零售供應商。該公司直接向消費者分發處方和非處方藥物、營養補充劑、跳蚤和蜱蟲控制產品以及一系列寵物健康用品。通過其位於佛羅里達州德爾雷海灘的持牌獸醫藥房，PetMed Express 為狗、貓和其他伴侶動物處理訂單，提供品牌和仿製產品以及自有品牌配方。</p>
</div><p>Founded in 1996 by Marc Puleo, PetMed Express built its business on the premise of convenience and cost savings for pet owners seeking reliable access to veterinary medications.</p>
<div class="lb-trans"><p>PetMed Express 於 1996 年由 Marc Puleo 創立，基於為尋求可靠獸醫藥物的寵物主人提供便利和節省成本的理念建立了其業務。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推薦故事</h2>
</div><ul>
<li>Five stocks we like better than PetMed Express</li>
<li>This AI Opportunity Was Built to Evolve With Demand</li>
<li>Punch these codes into your ordinary brokerage account</li>
<li>How a Family Trust May Be Able To Help Preserve Your Wealth</li>
<li>Why Trump and Musk suddenly care about Fort Knox</li>
<li>A U.S. “birthright” claim worth trillions - activated quietly</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票比 PetMed Express 更好</li>
<li>這個 AI 機會旨在隨着需求的變化而發展</li>
<li>將這些代碼輸入您的普通經紀賬户</li>
<li>家族信託如何幫助保護您的財富</li>
<li>為什麼特朗普和馬斯克突然關心福特諾克斯</li>
<li>一項價值數萬億的美國 “出生權” 索賠 - 靜悄悄地激活</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞警報由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in PetMed Express Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 PetMed Express 嗎？</h2>
</div><p>Before you consider PetMed Express, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 PetMed Express 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PetMed Express wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買……而 PetMed Express 並不在名單上。</p>
</div><p>While PetMed Express currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 PetMed Express 目前在分析師中被評為 “賣出”，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

PetMed Express, Inc.（NASDAQ 代碼：PETS）的空頭頭寸減少了 60.9%